AbbVie, Shire close on $53B deal

|About: AbbVie Inc. (ABBV)|By:, SA News Editor

After many weeks of takeover talks, AbbVie (NYSE:ABBV) has finally closed on a $53B deal with Shire (NASDAQ:SHPG) in the pursuit of a strategic tax inversion and new drug portfolio.

Under the cash-and-stock deal, AbbVie will pay £52.48 per share for Dublin-based Shire, consisting of £24.44 in cash and 0.8960 of new AbbVie shares.